Anaphylaxis: evidence-based long-term risk reduction in the community
- PMID: 17493500
- DOI: 10.1016/j.iac.2007.03.007
Anaphylaxis: evidence-based long-term risk reduction in the community
Abstract
Anaphylaxis occurs frequently in the community, and it can be fatal in community settings. Risk assessment and risk reduction should ideally be coordinated by an allergy/immunology specialist and focus on: (1) prevention of subsequent anaphylaxis episodes, (2) emergency preparedness, and (3) anaphylaxis education. Preventive strategies should include trigger avoidance, specific preventive measures, and optimal management of comorbidities. Despite best efforts to avoid anaphylaxis triggers they can be encountered inadvertently, and anaphylaxis episodes can and do recur. Risk reduction therefore also focuses on emergency preparedness: carrying self-injectable epinephrine, having a personalized Anaphylaxis Emergency Action Plan, and wearing accurate medical identification. Anaphylaxis education should involve not only at-risk individuals and their families, but also health care professionals and the general public.
Similar articles
-
Anaphylaxis, killer allergy: long-term management in the community.J Allergy Clin Immunol. 2006 Feb;117(2):367-77. doi: 10.1016/j.jaci.2005.12.002. J Allergy Clin Immunol. 2006. PMID: 16461138 Review.
-
Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community.J Allergy Clin Immunol. 2005 Mar;115(3):575-83. doi: 10.1016/j.jaci.2004.12.1122. J Allergy Clin Immunol. 2005. PMID: 15753907 Review.
-
Self-injectable epinephrine for first-aid management of anaphylaxis.Pediatrics. 2007 Mar;119(3):638-46. doi: 10.1542/peds.2006-3689. Pediatrics. 2007. PMID: 17332221 Review.
-
Anaphylaxis.J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S161-81. doi: 10.1016/j.jaci.2009.12.981. J Allergy Clin Immunol. 2010. PMID: 20176258 Review.
-
Epinephrine and its use in anaphylaxis: current issues.Curr Opin Allergy Clin Immunol. 2010 Aug;10(4):354-61. doi: 10.1097/ACI.0b013e32833bc670. Curr Opin Allergy Clin Immunol. 2010. PMID: 20543673 Review.
Cited by
-
Emergency treatment of anaphylaxis.BMJ. 2008 May 24;336(7654):1141-2. doi: 10.1136/bmj.39547.452153.80. BMJ. 2008. PMID: 18497373 Free PMC article.
-
Comparison of the efficacy of continuous intravenous infusion versus intramuscular injection of epinephrine for initial anaphylaxis treatment.Acute Med Surg. 2022 Oct 20;9(1):e790. doi: 10.1002/ams2.790. eCollection 2022 Jan-Dec. Acute Med Surg. 2022. PMID: 36285105 Free PMC article.
-
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel.J Allergy Clin Immunol. 2010 Dec;126(6 Suppl):S1-58. doi: 10.1016/j.jaci.2010.10.007. J Allergy Clin Immunol. 2010. PMID: 21134576 Free PMC article.
-
Long-term effectiveness of online anaphylaxis education for pharmacists.Am J Pharm Educ. 2014 Sep 15;78(7):136. doi: 10.5688/ajpe787136. Am J Pharm Educ. 2014. PMID: 25258441 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical